RMD: 10-Q financial filing

rmd-20260930 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2026 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______to _______ Commission File Number: 001-15317 ______________________________________________________________________________________________ ResMed Inc. (Exact name of registrant as specified in its charter) ______________________________________________________________________________________________ Delaware (State or other jurisdiction of incorporation or organization) 98-0152841 (I.R.S. Employer Identification No.) 9001 Spectrum Center Blvd. San Diego , CA 92123 United States of America (Address of principal executive offices, including zip code) ( 858 ) 836-5000 (Registrant’s telephone number, including area code) ______________________________________________________________________________________________ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.004 per share RMD New York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filin